These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 1340160)

  • 1. Antisense promoter mapping. Inhibitory methods of transcriptional analysis.
    Holt JT
    Ann N Y Acad Sci; 1992 Oct; 660():88-94. PubMed ID: 1340160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antisense mapping of the c-fos promoter: role of the serum response element.
    Robinson-Benion C; Kamata N; Holt JT
    Antisense Res Dev; 1991; 1(1):21-33. PubMed ID: 1822246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional regulation of sertoli cell differentiation by follicle-stimulating hormone at the level of the c-fos and transferrin promoters.
    Chaudhary J; Whaley PD; Cupp A; Skinner MK
    Biol Reprod; 1996 Mar; 54(3):692-9. PubMed ID: 8835393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of fra-2 gene expression.
    Yoshida T; Suzuki T; Sato H; Nishina H; Iba H
    Nucleic Acids Res; 1993 Jun; 21(11):2715-21. PubMed ID: 7687344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of specific response elements of the c-fos promoter and involvement of intermediate transcription factor(s) in the induction of Sertoli cell differentiation (transferrin promoter activation) by the testicular paracrine factor PModS.
    Whaley PD; Chaudhary J; Cupp A; Skinner MK
    Endocrinology; 1995 Jul; 136(7):3046-53. PubMed ID: 7789331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antisense targeting of c-fos transcripts inhibits serum- and TGF-beta 1-stimulated PAI-1 gene expression and directed motility in renal epithelial cells.
    Kutz SM; Providence KM; Higgins PJ
    Cell Motil Cytoskeleton; 2001 Mar; 48(3):163-74. PubMed ID: 11223948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic increase in c-fos expression by simultaneous activation of the ras/raf/map kinase- and protein kinase A signaling pathways is mediated by the c-fos AP-1 and SRE sites.
    Seternes OM; Sørensen R; Johansen B; Loennechen T; Aarbakke J; Moens U
    Biochim Biophys Acta; 1998 Feb; 1395(3):345-60. PubMed ID: 9512670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nerve growth factor transcriptional control of c-fos promoter transfected in cultured spinal sensory neurons.
    Gabellini N; Minozzi MC; Leon A; Dal Toso R
    J Cell Biol; 1992 Jul; 118(1):131-8. PubMed ID: 1618900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastrin induces c-fos gene transcription via multiple signaling pathways.
    Stepan VM; Tatewaki M; Matsushima M; Dickinson CJ; del Valle J; Todisco A
    Am J Physiol; 1999 Feb; 276(2):G415-24. PubMed ID: 9950815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of c-fos expression in the butyrate-induced F-98 glioma cell differentiation.
    Tang SJ; Huang YM; Wang FF
    Biochem J; 1995 Feb; 306 ( Pt 1)(Pt 1):47-56. PubMed ID: 7864828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary characterisation of mechanoresponsive regions of the c-fos promoter in bone cells.
    Peake MA; El Haj AJ
    FEBS Lett; 2003 Feb; 537(1-3):117-20. PubMed ID: 12606042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The hepatitis B virus X protein transactivation of c-fos and c-myc proto-oncogenes is mediated by multiple transcription factors.
    Avantaggiati ML; Balsano C; Natoli G; De Marzio E; Will H; Elfassi E; Levrero M
    Arch Virol Suppl; 1992; 4():57-61. PubMed ID: 1450726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastrin regulates the human histidine decarboxylase promoter through an AP-1-dependent mechanism.
    Höcker M; Zhang Z; Merchant JL; Wang TC
    Am J Physiol; 1997 Apr; 272(4 Pt 1):G822-30. PubMed ID: 9142914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutting the chain of command: specific inhibitors of transcription.
    Holt JT
    Antisense Res Dev; 1991; 1(4):365-9. PubMed ID: 1821658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of transformed phenotypes by antisense fos.
    Bradley MO; Manam S; Kraynak AR; Nichols WW; Ledwith BJ
    Ann N Y Acad Sci; 1992 Oct; 660():124-35. PubMed ID: 1340116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure and mapping of the fosB gene. FosB downregulates the activity of the fosB promoter.
    Lazo PS; Dorfman K; Noguchi T; Mattéi MG; Bravo R
    Nucleic Acids Res; 1992 Jan; 20(2):343-50. PubMed ID: 1741260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene transplantation: combined antisense inhibition and gene replacement strategies.
    Robinson-Benion C; Li YX; Holt JT
    Leukemia; 1994 Apr; 8 Suppl 1():S152-5. PubMed ID: 8152283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional antagonist cAMP-responsive element modulator (CREM) down-regulates c-fos cAMP-induced expression.
    Foulkes NS; Laoide BM; Schlotter F; Sassone-Corsi P
    Proc Natl Acad Sci U S A; 1991 Jun; 88(12):5448-52. PubMed ID: 1647033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Fos and Jun/AP-1 proteins are involved in the downregulation of Fos transcription.
    Schönthal A; Büscher M; Angel P; Rahmsdorf HJ; Ponta H; Hattori K; Chiu R; Karin M; Herrlich P
    Oncogene; 1989 May; 4(5):629-36. PubMed ID: 2498806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phorbol ester inhibition of rat gonadotropin-releasing hormone promoter activity: role of Fos and Jun in the repression of transcription.
    Bruder JM; Spaulding AJ; Wierman ME
    Mol Endocrinol; 1996 Jan; 10(1):35-44. PubMed ID: 8838143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.